ArticleClinical cancer research : an official journal of the American Association for Cancer Research2010

Improved potency and selectivity of an oncolytic E1ACR2 and E1B19K deleted adenoviral mutant in prostate and pancreatic cancers.

Daniel Oberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.